scholarly journals Efficient Multi-Objective Molecular Optimization in a Continuous Latent Space

Author(s):  
Robin Winter ◽  
Floriane Montanari ◽  
Andreas Steffen ◽  
Hans Briem ◽  
Frank Noé ◽  
...  

In this work, we propose a novel method that combines in silico prediction of molecular properties such as biological activity or pharmacokinetics with an in silico optimization algorithm, namely Particle Swarm Optimization. Our method takes a starting compound as input and proposes new molecules with more desirable (predicted) properties. It navigates a machine-learned continuous representation of a drug-like chemical space guided by a de fined objective function. The objective function combines multiple in silico prediction models, de fined desirability ranges and substructure constraints. We demonstrate that our proposed method is able to consistently fi nd more desirable molecules for the studied tasks in relatively short time.<br>

Author(s):  
Robin Winter ◽  
Floriane Montanari ◽  
Andreas Steffen ◽  
Hans Briem ◽  
Frank Noé ◽  
...  

In this work, we propose a novel method that combines in silico prediction of molecular properties such as biological activity or pharmacokinetics with an in silico optimization algorithm, namely Particle Swarm Optimization. Our method takes a starting compound as input and proposes new molecules with more desirable (predicted) properties. It navigates a machine-learned continuous representation of a drug-like chemical space guided by a de fined objective function. The objective function combines multiple in silico prediction models, de fined desirability ranges and substructure constraints. We demonstrate that our proposed method is able to consistently fi nd more desirable molecules for the studied tasks in relatively short time.<br>


2019 ◽  
Vol 16 (5) ◽  
pp. 1851-1863 ◽  
Author(s):  
Rikiya Ohashi ◽  
Reiko Watanabe ◽  
Tsuyoshi Esaki ◽  
Tomomi Taniguchi ◽  
Nao Torimoto-Katori ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (98) ◽  
pp. 80634-80642 ◽  
Author(s):  
Chul-Woong Cho ◽  
Stefan Stolte ◽  
Yeoung-Sang Yun ◽  
Ingo Krossing ◽  
Jorg Thöming

Prediction models for LFER descriptors – excess molar refraction (E), dipolarity/polarizability (S), H-bonding acidity (A) & basicity (B), McGowan volume (V), and interaction of cations (J+) and anions (J−) – of both ionic and neutral compounds.


2020 ◽  
Vol 36 (13) ◽  
pp. 4093-4094
Author(s):  
Robin Winter ◽  
Joren Retel ◽  
Frank Noé ◽  
Djork-Arné Clevert ◽  
Andreas Steffen

Abstract Summary Optimizing small molecules in a drug discovery project is a notoriously difficult task as multiple molecular properties have to be considered and balanced at the same time. In this work, we present our novel interactive in silico compound optimization platform termed grünifai to support the ideation of the next generation of compounds under the constraints of a multiparameter objective. grünifai integrates adjustable in silico models, a continuous representation of the chemical space, a scalable particle swarm optimization algorithm and the possibility to actively steer the compound optimization through providing feedback on generated intermediate structures. Availability and implementation Source code and documentation are freely available under an MIT license and are openly available on GitHub (https://github.com/jrwnter/gruenifai). The backend, including the optimization method and distribution on multiple GPU nodes is written in Python 3. The frontend is written in ReactJS.


2019 ◽  
Vol 15 (5) ◽  
pp. 561-570 ◽  
Author(s):  
Sanjay Kumar ◽  
Shiv Gupta ◽  
Shraddha Gaikwad ◽  
Leila F. Abadi ◽  
Late K. K. Bhutani ◽  
...  

Background: Natural products have shown potent anti-HIV activity, but some of these also possess toxicity. The pharmacophoric fragments of these natural products have scope of combination with other pharmacophoric fragment and derivatization to reduce toxicity and increase the potency. Combination of natural product fragments from different classes of anti–HIV compounds may lead to a new class of potent anti–HIV agents. Objective: Design, in silico prediction of drug-likeness, ADMET properties and synthesis of pyrazol– pyridones. Evaluation of the anti–HIV–1 activity of synthesized pyrazol–pyridones. Methods: Pyrazol–pyridones were designed by combining reported anti–HIV pharmacophoric fragments. Designed molecules were synthesized after in silico prediction of drug-likeness and ADMET properties. Compounds were evaluated for activity against HIV–1VB59 and HIV–1UG070. Results: QED value of designed pyrazol–pyridones was greater than the known drug zidovudine. The designed compounds were predicted to be noncarcinogenic and nonmutagenic in nature. Seventeen novel pyrazol–pyridones were synthesized with good yield. Compound 6q and 6l showed activity with IC50 values 6.14 µM and 15.34 µM against HIV–1VB59 and 16.21 µM and 18.21 µM against HIV–1UG070, respectively. Conclusion: Compound 6q was found to be most potent among the synthesized compounds with a therapeutic index of 54.31against HIV–1VB59. This is the first report of anti–HIV–1 activity of pyrazol–pyridone class of compounds. Although the anti–HIV–1 activity of these compounds is moderate, this study opens up a new class for exploration of chemical space for anti–HIV–1 activity.


Sign in / Sign up

Export Citation Format

Share Document